Su et al. [45] earlier suggested that IL-6 modulated Hhg signaling in leukemia, but our finding of IL-6 modulation of Hhg signaling in CD133+ CSC-like cells of NSCLC has not been reported previously. The gene discussed is PROM1; the disease is non-small cell lung carcinoma.